Saturna Capital CORP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
Saturna Capital CORP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$33,558,897
+6.7%
329,461
+5.7%
0.59%
+9.2%
Q2 2023$31,450,216
+10.2%
311,666
+0.5%
0.54%
-1.6%
Q1 2023$28,544,472
+1.3%
310,266
-0.1%
0.55%
-8.7%
Q4 2022$28,186,341
+13.7%
310,696
-4.8%
0.61%
+0.2%
Q3 2022$24,796,000
-10.0%
326,215
+0.1%
0.60%
-7.2%
Q2 2022$27,553,000
-3.6%
325,958
+0.1%
0.65%
+13.2%
Q1 2022$28,584,000
-0.5%
325,738
+1.8%
0.58%
+11.8%
Q4 2021$28,720,000
+9.3%
320,128
-0.4%
0.52%
-2.5%
Q3 2021$26,274,000
+1.5%
321,278
+13.3%
0.53%
-0.6%
Q2 2021$25,882,000
+7.8%
283,673
+1.0%
0.53%
-0.9%
Q1 2021$24,018,000
-14.3%
280,973
-5.3%
0.54%
-15.3%
Q4 2020$28,013,000
+8.8%
296,653
+0.2%
0.63%
-3.5%
Q3 2020$25,757,000
-0.3%
296,193
+0.1%
0.66%
-9.5%
Q2 2020$25,835,000
-0.3%
295,803
+0.1%
0.72%
-13.6%
Q1 2020$25,909,000
-5.6%
295,403
+2.0%
0.84%
+13.1%
Q4 2019$27,434,000
+9.5%
289,728
+0.5%
0.74%
+1.9%
Q3 2019$25,056,000
-4.2%
288,328
+0.6%
0.73%
-5.2%
Q2 2019$26,160,000
-5.0%
286,494
+0.0%
0.77%
-4.5%
Q1 2019$27,539,000
+10.9%
286,444
-1.0%
0.80%
-3.8%
Q4 2018$24,836,000
-0.4%
289,428
+0.0%
0.84%
+15.2%
Q3 2018$24,933,000
+14.0%
289,378
-0.1%
0.73%
+3.6%
Q2 2018$21,878,000
-60.2%
289,628
-57.4%
0.70%
-59.9%
Q1 2018$54,916,000
-3.7%
679,228
+0.0%
1.75%
+0.1%
Q4 2017$57,003,000
-2.2%
678,9280.0%1.74%
-7.5%
Q3 2017$58,286,000
+1.9%
678,928
-0.9%
1.89%
-0.5%
Q2 2017$57,177,000
+12.3%
685,003
-0.0%
1.90%
+9.7%
Q1 2017$50,894,000
+2.1%
685,253
+0.1%
1.73%
-1.3%
Q4 2016$49,844,000
-34.2%
684,294
-28.7%
1.75%
-29.2%
Q3 2016$75,762,000
-13.3%
959,494
-9.4%
2.47%
-11.7%
Q2 2016$87,427,000
+7.7%
1,059,594
-0.0%
2.80%
+7.7%
Q1 2016$81,190,000
-12.6%
1,060,044
-1.9%
2.60%
-9.3%
Q4 2015$92,927,000
-6.4%
1,080,044
-0.0%
2.87%
-8.1%
Q3 2015$99,297,000
-6.5%
1,080,2560.0%3.12%
+4.7%
Q2 2015$106,232,000
-1.8%
1,080,256
-0.0%
2.98%
+2.7%
Q1 2015$108,232,000
+4.7%
1,080,556
-3.1%
2.90%
+7.5%
Q4 2014$103,339,000
-1.6%
1,115,2530.0%2.70%
-3.9%
Q3 2014$104,979,000
+4.0%
1,115,253
+0.0%
2.81%
+7.1%
Q2 2014$100,946,000
+6.5%
1,115,0530.0%2.63%
+5.3%
Q1 2014$94,802,000
-0.2%
1,115,053
-5.7%
2.49%
+2.8%
Q4 2013$94,997,000
+4.8%
1,181,8530.0%2.42%
+0.7%
Q3 2013$90,660,000
+8.5%
1,181,8530.0%2.41%
+5.4%
Q2 2013$83,569,0001,181,8532.28%
Other shareholders
NOVARTIS A G shareholders Q4 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders